Global Ganja Report

Small producers have long been wary of the cannabis industry coming under domination by multi-state operators with the worst practices of corporate America. But the revelations of Russian oligarch money in the coffers of leading MSO Curaleaf appear to vindicate even the most cynical observers. These follow a slew of controversies concerning product safety and labor rights at the company.

It’s a fairly open secret that Brittney Griner was Putin’s geopolitical pawn when she was in Russian detention for nine months on a minor cannabis charge. And her freedom came at a high price—swapped for a Russian “Death Merchant” who now boasts he’ll aid Putin’s savage war in Ukraine. But GOP exploitation of Griner indicates that she remains a political pawn even as a free woman in America.

With political and legal space opening for cannabis in state after state, a backlash is manifesting in the idea of caps on the potency—whether of bud, extracts or edibles. Voices from the industry and activist community see this as a throwback to the days of Reefer Madness.

With growing legal and cultural space for cannabis, can the mere smell of the stuff still be sufficient cause for a search that could potentially land you in jail? The answer is that the courts are divided on this question. Meanwhile, cannabis attorneys warn against the fatal error of consenting to a search.

The sex scandal investigation of Florida's far-right Rep. Matt Gaetz interlocks with a controversy concerning favoritism in handing out medical marijuana licenses in the Sunshine State. And one of the key beneficiaries appears to be Trulieve, now one of the leading cannabis companies in the United States. The origins of the firm go back to a nexus of prominent state Republicans, including names currently making stomach-churning national headlines.

As political and legal space opens for cannabis in state after state, the idea of caps on the potency — whether of flower, extracts or edibles — is gaining currency. But voices in the cannabis industry view this as a phobic response rooted in the flawed assumptions of prohibition.

Among the ambiguous areas in the state medical marijuana laws from coast to coast is the status of cannabis and its derivatives as veterinary medications. Now, a new non-profit has been launched to advocate for legal standards and clarity on the question.

Even as the edifice of cannabis prohibition crumbles state by state, the federal illegality of the plant and its psychoactive compound THC continues to drive a quest for loopholes in the relevant statutes.


The latest such legal artifice concerns Delta-8 tetrahydrocannabinol — a less potent cannabinoid than the more common and notorious Delta-9 THC. Is there truth to the claim that hemp-derived Delta-8 THC was inadvertently legalized by the 2018 Farm Bill?